Literature DB >> 341069

Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock.

L J Fenton, R C Strunk.   

Abstract

Serial measurements of CH50, C3, C4, and factor B were performed on three newborn infants with group B streptococcal sepsis. Two of the septic infants had a colonized but noninfected identical twin. All three infants with group B streptococcal sepsis had hypotension, prolonged coagulation times, neutropenia, and respiratory failure. During the course of the sepsis, factor B was depressed 30% to 35%, C3 was depressed 40% to 60%, and CH50 was depressed by 100% when compared to their cord blood levels. Two of the infants also had a 50% to 70% depression of C4. In contrast, no significant decrease in complement levels occurred in the siblings of the twins or in two additional control infants. These data are characteristic of older patients with Gram-negative sepsis and strongly suggest that the group B Streptococcus has endotoxin-like properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 341069

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Component concentrations and activation of the complement system in neonatal illness: a preliminary study of necrotizing enterocolitis.

Authors:  D K Stevenson; Y P Hsu; M McMorrow; C L Berseth; J Neu; J J Miller
Journal:  Eur J Pediatr       Date:  1980-09       Impact factor: 3.183

4.  Effects of fibronectin and group B streptococci on tumour necrosis factor-alpha production by human culture-derived macrophages.

Authors:  E B Peat; N H Augustine; W K Drummond; J F Bohnsack; H R Hill
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

5.  Possible induction of disseminated intravascular coagulation in the mouse by group B streptococcal clumping factor.

Authors:  Y Usui; Y Ichiman; K Yoshida; K Oikawa
Journal:  Br J Exp Pathol       Date:  1986-10

6.  Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.

Authors:  C G Hellerqvist; G B Thurman; D L Page; Y F Wang; B A Russell; C A Montgomery; H W Sundell
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

8.  Molecular basis for group B beta-hemolytic streptococcal disease.

Authors:  C G Hellerqvist; H Sundell; P Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.

Authors:  Ofer Levy; Rochelle M Jean-Jacques; Colette Cywes; Richard B Sisson; Kol A Zarember; Paul J Godowski; Jennifer L Christianson; Hilde-Kari Guttormsen; Michael C Carroll; Anne Nicholson-Weller; Michael R Wessels
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.

Authors:  S E Goldblum; W P Reed
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.